Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trialViviane Hess, Marc Salzberg, Markus Borner, et al.Onkologie|June 29, 2007
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancerMarc Salzberg, Christoph Rochlitz, Rudolf Morant, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 28, 2004
Chemotherapy-induced nausea and vomiting in routine practice: a European perspectiveAgnes Glaus, Cornelia Knipping, Rudolf Morant, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 27, 2013
Multidisciplinary care in patients with prostate cancer: room for improvementRäto T Strebel, Tullio Sulser, Hans-Peter Schmid, et al.Clinical Genitourinary Cancer|September 30, 2017
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment RegistryFrank Stenner, Sacha I Rothschild, Daniel Betticher, et al.Cancer Chemotherapy and Pharmacology|July 30, 2005
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinomaMonika Jermann, Rolf A Stahel, Marc Salzberg, et al.Cancer Gene Therapy|March 16, 2002
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levelsChristoph Rochlitz, Brigitte Dreno, Peter Jantscheff, et al.British Journal of Haematology|October 18, 2005
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myelomaHeinz Ludwig, Ivan Spicka, Pavel Klener, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 18, 2023
Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical ProstatectomyChristian Ruiz, Ilaria Alborelli, Massimilinao Manzo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerMarkus M Borner, Daniel Dietrich, Roger Stupp, et al.Pageof 3